Results 71 to 80 of about 1,131,297 (298)

Medical Interpreters in Outpatient Practice

open access: yesAnnals of Family Medicine, 2018
This article provides an overview of the federal requirements related to providing interpreter services for non-English–speaking patients in outpatient practice.
B. Jacobs   +3 more
semanticscholar   +1 more source

Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein   +7 more
wiley   +1 more source

The impact of post-COVID syndrome across a multitude of health domains: a comparative analysis in previously hospitalized versus non-hospitalized COVID-19 survivors

open access: yesMonaldi Archives for Chest Disease
This study aimed to evaluate the impact of post-COVID syndrome across a multitude of health domains among COVID-19 survivors via comparative analysis in previously hospitalized vs. non-hospitalized patients.
Elif Yildirim   +5 more
doaj   +1 more source

Feasibility of outpatient total hip and knee arthroplasty in unselected patients

open access: yesActa Orthopaedica, 2017
Background and purpose — The number of patients who are suitable for outpatient total hip and knee arthroplasty (THA and TKA) in an unselected patient population remains unknown.
K. Gromov   +4 more
semanticscholar   +1 more source

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund   +3 more
wiley   +1 more source

Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew   +11 more
wiley   +1 more source

Psychiatric outpatients flow and waiting time improvement using PDSA and RCA techniques

open access: yesPayesh, 2016
Objective (s): Waits and delays are symptoms of disrupted patient flow that has a negative effect on patient satisfaction, staff retention and referrals.
Seyedeh Hamideh Ghazimirsaeid   +1 more
doaj  

Peginterferon-lambda for the treatment of COVID-19 in outpatients [PDF]

open access: green, 2020
Jordan J. Feld   +34 more
openalex   +1 more source

Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang   +8 more
wiley   +1 more source

More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?

open access: yesHematology
Haploidentical hematopoietic can be conducted on an outpatient basis but the two main reasons to accept into the hospital a patient in this setting are complications of the hematological toxicity and/or the cytokine-release syndrome.
Moisés Manuel Gallardo-Pérez   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy